Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 20, 2017 10:32 ET | Source: Calithera Biosciences, Inc.

CB-1158 Phase I Data Accepted for an Oral Presentation at the ASCO Annual Meeting

SOUTH SAN FRANCISCO, Calif., April 20, 2017 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small...
March 29, 2017 07:00 ET | Source: Calithera Biosciences, Inc.

Calithera Biosciences to Present at the 16th Annual Needham Health Care Conference

SOUTH SAN FRANCISCO, Calif., March 29, 2017 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small...
March 28, 2017 07:00 ET | Source: Calithera Biosciences, Inc.

Calithera to Receive $12 Million Milestone Payment From Incyte for Achievement of Pharmacokinetic and Pharmacodynamic Goals in Phase 1 Study

SOUTH SAN FRANCISCO, Calif., March 28, 2017 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small...
March 27, 2017 16:04 ET | Source: Calithera Biosciences, Inc.

Calithera Biosciences, Inc. Announces Closing of Public Offering and Exercise in Full of Option to Purchase Additional Shares

SOUTH SAN FRANCISCO, Calif., March 27, 2017 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (NASDAQ:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small...
March 22, 2017 07:00 ET | Source: Calithera Biosciences, Inc.

Calithera Biosciences, Inc. Prices Public Offering of 6,830,000 shares of Common Stock

SOUTH SAN FRANCISCO, Calif., March 22, 2017 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (NASDAQ:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small...
March 20, 2017 16:02 ET | Source: Calithera Biosciences, Inc.

Calithera Biosciences, Inc. Announces Commencement of Underwritten Public Offering of Common Stock

SOUTH SAN FRANCISCO, Calif., March 20, 2017 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (NASDAQ:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small...
March 16, 2017 16:06 ET | Source: Calithera Biosciences, Inc.

Calithera Biosciences Reports Fourth Quarter and Full Year 2016 Financial Results and Recent Highlights

SOUTH SAN FRANCISCO, Calif., March 16, 2017 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small...
March 10, 2017 07:00 ET | Source: Calithera Biosciences, Inc.

Calithera Biosciences to Report Fourth Quarter and Year-End 2016 Financial Results on Thursday, March 16, 2017

SOUTH SAN FRANCISCO, Calif., March 10, 2017 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small...
March 01, 2017 07:00 ET | Source: Calithera Biosciences, Inc.

Calithera Biosciences to Present at Cowen and Company 37th Annual Health Care Conference

SOUTH SAN FRANCISCO, Calif., March 01, 2017 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small...
February 09, 2017 07:00 ET | Source: Calithera Biosciences, Inc.

Calithera Biosciences to Present at the BIO CEO & Investor and Leerink Global Healthcare Conferences in February

SOUTH SAN FRANCISCO, Calif., Feb. 09, 2017 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small...